APA

Van Ranst P. C., Snoeck H. W., Lardon F., Lenjou M., Nijs G., Weekx S. F., Rodrigus I., Berneman Z. N. & Van Bockstaele D. R. (19961226). TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors. : Experimental hematology.

Chicago

Van Ranst P C, Snoeck H W, Lardon F, Lenjou M, Nijs G, Weekx S F, Rodrigus I, Berneman Z N and Van Bockstaele D R. 19961226. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors. : Experimental hematology.

Harvard

Van Ranst P. C., Snoeck H. W., Lardon F., Lenjou M., Nijs G., Weekx S. F., Rodrigus I., Berneman Z. N. and Van Bockstaele D. R. (19961226). TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors. : Experimental hematology.

MLA

Van Ranst P C, Snoeck H W, Lardon F, Lenjou M, Nijs G, Weekx S F, Rodrigus I, Berneman Z N and Van Bockstaele D R. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors. : Experimental hematology. 19961226.